<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4760</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJCRR.2023.151701</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	Human Papillomavirus(HPV) Vaccination in India: Challenges and The Way Forward&#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>Shivangi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jangili</surname><given-names>Hephzibah Blessy</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>11</day><month>09</month><year>2023</year></pub-date><volume>7)</volume><issue/><fpage>1</fpage><lpage>2</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	The World Health Organisation understands the importance of routine HPV vaccinationin national immunisation regimens because cervical cancer and other HPV-related illnesses are major global public health issues. Regardless of the Indian government’s efforts to include HPV vaccination in the National Immunisation Programme and decrease vaccine costs, there are significant barriers to vaccination implementation in India, including insufficient epidemiological evidence for illness prioritisation, vaccine duration, parental attitudes, and vaccine acceptance. Research studies should consider the wider context of improving life-long immunisation, comprehensive adolescent primary health care, and screening of cervical cancer. Educational measures for healthcare staff, followed by socially and culturally sensitive public awareness campaigns, are critical to meeting the WHO objective of eliminating cervical cancer by 2030.&#13;
&#13;
</p></abstract><kwd-group><kwd>Cervical cancer</kwd><kwd> HPV vaccine</kwd><kwd> Human papillomavirus</kwd><kwd> Prevention</kwd></kwd-group></article-meta></front></article>
